| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00213-012-2919-2 |
| P698 | PubMed publication ID | 23184281 |
| P2093 | author name string | A D Le | |
| W Lau | |||
| G A Higgins | |||
| P J Fletcher | |||
| D K H Lee | |||
| I A M de Lannoy | |||
| J Izhakova | |||
| K Coen | |||
| L B Silenieks | |||
| P2860 | cites work | Suicidal behavior and depression in smoking cessation treatments | Q21089921 |
| Functional Selectivity and Classical Concepts of Quantitative Pharmacology | Q22242288 | ||
| PDE4 inhibitors: current status | Q24651926 | ||
| Pharmacological targeting of the serotonergic system for the treatment of obesity | Q24658013 | ||
| Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells | Q24675490 | ||
| Regulation of serotonin-2C receptor G-protein coupling by RNA editing | Q28238375 | ||
| Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence | Q28266734 | ||
| Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid | Q28278033 | ||
| Serotonergic drugs : effects on appetite expression and use for the treatment of obesity | Q28282364 | ||
| Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors | Q28291458 | ||
| Influence of the 5-HT(2C) receptor antagonist SB242,084 on behaviour produced by the 5-HT(2) agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramine | Q28366550 | ||
| Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study | Q28377153 | ||
| The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination | Q28576908 | ||
| Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats | Q48608961 | ||
| Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement | Q48655865 | ||
| Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure | Q48881667 | ||
| Blockade by neuroleptics of water intake and operant responding for water in the rat: anhedonia, motor deficit, or both? | Q48960627 | ||
| Genotoxicity of 2-(3-chlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activation | Q50073282 | ||
| Evidence that the reward attenuating effect of the D1-like antagonist, SCH-23390, is not mediated by its agonist action at the 5-HT2c receptors. | Q51898536 | ||
| Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis. | Q52177592 | ||
| Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs. | Q52212856 | ||
| Chin rub CRs may reflect conditioned sickness elicited by a lithium-paired sucrose solution | Q52235033 | ||
| Behavioural evidence thatd-fenfluramine-induced anorexia in the rat is not mediated by the 5-HT1A receptor subtype | Q60054748 | ||
| Serotonin and drug reward: focus on 5-HT2C receptors | Q34277384 | ||
| Agonist-receptor efficacy. II. Agonist trafficking of receptor signals | Q34304785 | ||
| Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats | Q34361706 | ||
| SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist | Q34432766 | ||
| 5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents | Q34544813 | ||
| CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity | Q34562888 | ||
| Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization | Q34746665 | ||
| Agonists of the serotonin 5-HT2C receptor: preclinical and clinical progression in multiple diseases. | Q34792305 | ||
| The effects of the selective 5-HT(2C) receptor antagonist SB 242084 on learned helplessness in male Fischer 344 rats | Q34889576 | ||
| Patterns of nicotinic receptor antagonism: nicotine discrimination studies | Q35265699 | ||
| Activation of lumbosacral 5-HT2C receptors induces bursts of rhythmic activity in sympathetic nerves to the vas deferens in male rats | Q35546420 | ||
| The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control | Q35837700 | ||
| Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy | Q35964545 | ||
| Predicting the emetic liability of novel chemical entities: a comparative study | Q36025372 | ||
| Central serotonin2C receptor: from physiology to pathology | Q36612158 | ||
| Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation | Q36850882 | ||
| Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats | Q37121061 | ||
| RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function | Q37191492 | ||
| Serotonin receptors as potential targets for modulation of nicotine use and dependence | Q37260932 | ||
| Opportunities for the replacement of animals in the study of nausea and vomiting | Q37332618 | ||
| Recognising nicotine: the neurobiological basis of nicotine discrimination | Q37382320 | ||
| Lorcaserin: an investigational serotonin 2C agonist for weight loss | Q37947448 | ||
| Pharmacological and genetic interventions in serotonin (5-HT)(2C) receptors to alter drug abuse and dependence processes | Q38001807 | ||
| The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats | Q39847841 | ||
| A conservative, single-amino acid substitution in the second cytoplasmic domain of the human Serotonin2C receptor alters both ligand-dependent and -independent receptor signaling | Q40038219 | ||
| Role of rat strain in the differential sensitivity to pharmaceutical agents and naturally occurring substances | Q40950090 | ||
| The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats | Q43228295 | ||
| Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists | Q43709865 | ||
| Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine | Q43769228 | ||
| Rapid desensitization of the serotonin(2C) receptor system: effector pathway and agonist dependence | Q44106343 | ||
| Nicotine maintains robust self-administration in rats on a limited-access schedule | Q44290531 | ||
| Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats. | Q44396470 | ||
| Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice. | Q45980285 | ||
| Interactions of serotonin (5-HT)2 receptor-targeting ligands and nicotine: locomotor activity studies in rats | Q46060476 | ||
| Potential of the rat model of conditioned gaping to detect nausea produced by rolipram, a phosphodiesterase-4 (PDE4) inhibitor | Q46331906 | ||
| Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats | Q46362490 | ||
| Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus | Q47866757 | ||
| Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats | Q48112581 | ||
| 5-HT(2C) receptor activation inhibits appetitive and consummatory components of feeding and increases brain c-fos immunoreactivity in mice. | Q48140056 | ||
| Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug users | Q48278580 | ||
| Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat. | Q48364549 | ||
| Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo | Q48374845 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 475-490 | |
| P577 | publication date | 2012-11-25 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles | |
| P478 | volume | 226 |
| Q42647430 | Behavioral, pharmacological and neuroanatomical analysis of serotonin 2C receptor agonism on maternal behavior in rats |
| Q35049574 | Characterization of the 5-HT2C receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesity |
| Q50227324 | Choice between delayed food and immediate opioids in rats: treatment effects and individual differences |
| Q47373147 | Effects of Lorcaserin on Cocaine and Methamphetamine Self-Administration and Reinstatement of Responding Previously Maintained by Cocaine in Rhesus Monkeys |
| Q58080217 | Effects of lorcaserin on reinstatement of responding previously maintained by cocaine or remifentanil in rhesus monkeys |
| Q47738255 | Evidence for a role of 5-HT2C receptors in the motor aspects of performance, but not the efficacy of food reinforcers, in a progressive ratio schedule. |
| Q92932843 | Hypophagia induced by hindbrain serotonin is mediated through central GLP-1 signaling and involves 5-HT2C and 5-HT3 receptor activation |
| Q50580794 | Increased temporal discounting after chronic stress in CHL1-deficient mice is reversed by 5-HT2C agonist Ro 60-0175. |
| Q47102484 | Interactions between metabolic, reward and cognitive processes in appetite control: Implications for novel weight management therapies. |
| Q37531165 | Lateral/basolateral amygdala serotonin type-2 receptors modulate operant self-administration of a sweetened ethanol solution via inhibition of principal neuron activity |
| Q97883048 | Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain |
| Q36432310 | Lorcaserin Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys |
| Q45051146 | Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats. |
| Q48013285 | Lorcaserin and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: Implications for understanding the anti-obesity property of 5-HT2C receptor agonists |
| Q43816354 | On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination |
| Q35991747 | Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures |
| Q47588598 | Role of impulsivity and reward in the anti-obesity actions of 5-HT2C receptor agonists |
| Q57174388 | Serotonin 5-HT Receptor Activation Suppresses Binge Intake and the Reinforcing and Motivational Properties of High-Fat Food |
| Q47595946 | The 5-HT2C receptor agonist meta-chlorophenylpiperazine (mCPP) reduces palatable food consumption and BOLD fMRI responses to food images in healthy female volunteers |
| Q47677518 | The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders |
| Q36930837 | The effects of pharmacological modulation of the serotonin 2C receptor on goal-directed behavior in mice |
Search more.